Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabelle

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|July 12, 2016
Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-upJ Norton, F Portet, A Gabelle, et al.
Stem Cell Research|January 25, 2019
Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 geneL Auboyer, C Monzo, D Wallon, et al.
Stem Cell Research|April 21, 2019
Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP geneL Auboyer, C Monzo, D Wallon, et al.
Annales Pharmaceutiques Francaises|January 12, 2015
[Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study]M L Tall, S Lehmann, E Diouf, et al.
Neurobiology of Disease|February 29, 2024
The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR studyS Schraen-Maschke, A Duhamel, J S Vidal, et al.
The Journal of Nutrition, Health & Aging|December 1, 2017
Editorial: Collaborative Efforts to Prevent Alzheimer's DiseaseJ Touchon, J Rosenbaum, P Aisen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 4, 2019
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practiceS Lehmann, C Paquet, C Malaplate-Armand, et al.
La Revue De Medecine Interne|November 29, 2016
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]E Magnin, J Dumurgier, E Bouaziz-Amar, et al.
Revue Neurologique|June 12, 2024
The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohortD Andriuta, M Roussel, G Chene, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|July 12, 2016
Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-upJ Norton, F Portet, A Gabelle, et al.
Stem Cell Research|January 25, 2019
Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 geneL Auboyer, C Monzo, D Wallon, et al.
Stem Cell Research|April 21, 2019
Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP geneL Auboyer, C Monzo, D Wallon, et al.
Annales Pharmaceutiques Francaises|January 12, 2015
[Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study]M L Tall, S Lehmann, E Diouf, et al.
Neurobiology of Disease|February 29, 2024
The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR studyS Schraen-Maschke, A Duhamel, J S Vidal, et al.
The Journal of Nutrition, Health & Aging|December 1, 2017
Editorial: Collaborative Efforts to Prevent Alzheimer's DiseaseJ Touchon, J Rosenbaum, P Aisen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 4, 2019
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practiceS Lehmann, C Paquet, C Malaplate-Armand, et al.
La Revue De Medecine Interne|November 29, 2016
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]E Magnin, J Dumurgier, E Bouaziz-Amar, et al.
Revue Neurologique|June 12, 2024
The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohortD Andriuta, M Roussel, G Chene, et al.
Pageof 2